Skip to content
facebook
twitter
linkedin
youtube
Toggle navigation
L36, 1 Macquarie Place, Sydney, NSW 2000
+61 2 8051 3043
info@raceoncology.com
Home
About
Science
Management team
Investors
News
CONTACT US
×
Contact Us
Δ
Zantrene Highly Effective in a Mouse Model of Extramedullary AML
Browse
Home
ASX Release
Zantrene Highly Effective in a Mouse Model of Extramedullary AML
17
Mar
Mar
, 17 ,
2022
Daniel Tillett
Zantrene-Highly-Effective-in-a-Mouse-Model-of-Extramedullary-AML
Download
Facebook
Tweet
LinkedIn
Related posts:
Expanded Heart Protection Discovery for Zantrene
Breakthrough Chemotherapy Heart Protection Discovery for Zantrene
Zantrene kills melanoma cancer cells that overproduce FTO
Post navigation
Previous
Previous post:
Next
Next post:
Race Oncology
Targeting Zantrene® towards better cancer outcomes
Contact Us
©2021 Race Oncology Ltd